1. Ministerio de Sanidad, Servicios Sociales e Igualdad. Estrategia en enfermedades reumáticas y musculoesqueléticas del Sistema Nacional de Salud. Estrategia aprobada por el Pleno del Consejo Interterritorial del Sistema Nacional de Salud el 20 de Dic de 201. Available from: http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/pdf/Estrategia_en_enfermedades_reumaticas_Accesible.pdf [accessed 08.12.16].
2. Review article: loss of response to anti-TNF treatments in Crohn's disease;Ben-Horin;Aliment Pharmacol Ther,2011
3. Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis;Fernández-Nebro;J Rheumatol,2007
4. Adherence to long-term therapies. Evidence for action;World Health Organization,2003
5. Medication adherence: its importance in cardiovascular outcomes;Ho;Circulation,2009